BioSpace News Archive

AXIM Biotechnologies, Inc. today announced that it has appointed Joseph Tauber, MD as Chief Medical Officer and Chairman of its Medical Advisory Board.

HALO Diagnostics (HALO Dx) now offers men with suspected metastatic and recurrent prostate cancer another groundbreaking advanced imaging option.

Vivera Pharmaceuticals, Inc. announced the launch of a joint vaccination initiative in Southern California.

Alzheimer’s and dementia impacted more than 55 million families worldwide and cost the global economy US$1.3 trillion in 2019, reaching an estimated cumulative cost of $20 trillion over the next decade

NetImpact Strategies, Inc. (NetImpact) was awarded the Portfolio Management Systems Support Services (PM3S) recompete contract to provide a broad range of digital transformation solutions including enterprise-wide portfolio management and strategic consulting for the Center for Biomedical Informatics and Information Technology (CBIIT), National Cancer Institute (NCI), National Institutes of Health (NIH).

Intrommune Therapeutics announced the appointment of Gerard Kugel, D.M.D., M.S., Ph.D. to serve on its scientific advisory board.

Co-Diagnostics, Inc. (Nasdaq: CODX), announced today that its Logix Smart™ Influenza A/Influenza B/COVID-19 “ABC” Test has been approved for sale in Mexico by the Mexican Department of Epidemiology (“InDRE”) after InDRE successfully concluded an independent evaluation of the test’s sensitivity and specificity for use as an RT-PCR multiplex test in that market.

jCyte, Inc., a private biotechnology company dedicated to improving the lives of patients with retinal degenerative diseases, announced the continued expansion of the Company’s leadership team with the appointment of Dr. Rebecca Kammer as Vice President of Clinical Operations.

JHU is recognized as a world leader in the development of image processing machine learning algorithms.

Revive Therapeutics Ltd. announces today that AdvisorShares® Investments LLC (“AdvisorShares”), a leading sponsor of actively managed exchange-traded funds (ETFs) has included Revive Therapeutics in the inaugural launch of its AdvisorShares Psychedelics